Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01159639
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01159639
-
- Other papers using this trial's data
- Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639)
- Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting
- Postoperative Atrial Fibrillation Is Associated With High On-Aspirin Platelet Reactivity
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Croatia
- Registry status
- Completed
Technical summary
Registry record NCT01159639. Randomized; no masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2013-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
- Condition
- Coronary Artery Disease
- Condition
- Aspirin Resistance
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- University of Zagreb
Record details
- Record id
cardio:ct-nct01159639- Content hash
c983e0669d1148b83da6b166de03dbdf23c57b63e78e513292c8068cf900872b